Polypeptides having lysozyme activity and compositions comprising it

US10039300B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10039300-B2
Application numberUS-201715495031-A
CountryUS
Kind codeB2
Filing dateApr 24, 2017
Priority dateNov 25, 2011
Publication dateAug 7, 2018
Grant dateAug 7, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to isolated polypeptides having lysozyme activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

First claim

Opening claim text (preview).

The invention claimed is: 1. A granule comprising a polypeptide having lysozyme activity, wherein the granule comprises a core particle comprising the polypeptide and one or more coatings, and wherein the polypeptide has at least 95% sequence identity to a polypeptide sequence having amino acids selected from the group consisting of amino acids 20 to 264 of SEQ ID NO: 2, amino acids 21 to 186 of SEQ ID NO: 4, and amino acids 20 to 176 of SEQ ID NO: 6. 2. The granule of claim 1 , wherein the polypeptide has at least 95% sequence identity to the polypeptide sequence of amino acids 20 to 264 of SEQ ID NO: 2. 3. The granule of claim 1 , wherein the polypeptide has at least 97% sequence identity to the polypeptide sequence of amino acids 20 to 264 of SEQ ID NO: 2. 4. The granule of claim 1 , wherein the polypeptide has at least 95% sequence identity to the polypeptide sequence of amino acids 21 to 186 of SEQ ID NO: 4. 5. The granule of claim 1 , wherein the polypeptide has at least 97% sequence identity to the polypeptide sequence of amino acids 21 to 186 of SEQ ID NO: 4. 6. The granule of claim 1 , wherein the polypeptide has at least 95% sequence identity to the polypeptide sequence of amino acids 20 to 176 of SEQ ID NO: 6. 7. The granule of claim 1 , wherein the polypeptide has at least 97% sequence identity to the polypeptide sequence of amino acids 20 to 176 of SEQ ID NO: 6. 8. The granule of claim 1 , wherein the polypeptide is encoded by a polynucleotide that hybridizes under high stringency conditions with the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 3 or SEQ ID NO: 5 or the full-length complement of thereof. 9. The granule of claim 1 , wherein the polypeptide is a variant of a polypeptide sequence having amino acids selected from the group consisting of amino acids 20 to 264 of SEQ ID NO: 2, amino acids 21 to 186 of SEQ ID NO: 4, and amino acids 20 to 176 of SEQ ID NO: 6, comprising a substitution, deletion, and/or insertion at one or more positions. 10. The granule of claim 1 , wherein the polypeptide is a fragment of a polypeptide sequence having amino acids selected from the group consisting of amino acids 20 to 264 of SEQ ID NO: 2, amino acids 21 to 186 of SEQ ID NO: 4, and amino acids 20 to 176 of SEQ ID NO: 6, which has lysozyme activity, wherein the fragment has at least 95% sequence identity to a polypeptide sequence of amino acids selected from the group consisting of amino acids 20 to 264 of SEQ ID NO: 2, amino acids 21 to 186 of SEQ ID NO: 4, and amino acids 20 to 176 of SEQ ID NO: 6. 11. The granule of claim 1 , wherein the polypeptide comprises the sequence of amino acids 20 to 264 of SEQ ID NO: 2. 12. The granule of claim 1 , wherein the polypeptide comprises the sequence of amino acids 21 to 186 of SEQ ID NO: 4. 13. The granule of claim 1 , wherein the polypeptide comprises the sequence of amino acids 20 to 176 of SEQ ID NO: 6. 14. A detergent composition comprising the granule of claim 1 and a surfactant. 15. The detergent composition of claim 14 , which further comprises one or more further enzymes selected from the group comprising of amylases, catalases, cellulases, cutinases, haloperoxygenases, lipases, mannanases, pectinases, pectin lyases, peroxidases, proteases, xanthanases, and xyloglucanases, or any mixture thereof. 16. The detergent composition of claim 14 , further comprising of one or more components selected from the group consisting of builders, hydrotopes, bleaching systems, polymers, fabric hueing agents, adjunct materials, dispersants, dye transfer inhibiting agents, fluorescent whitening agents, soil release polymers and anti-redeposition agents. 17. An animal feed composition comprising the granule of claim 1 . 18. The animal feed composition of claim 17 , which further comprises of one or more amylases; galactanases; alpha-galactosidases; beta-glucanases, phospholipases, phytases, proteases, and xylanases, or any mixture thereof. 19. An animal feed additive comprising at least one granule of claim 1 ; and at least one fat-soluble vitamin, and/or at least one water-soluble vitamin, and/or at least one trace mineral. 20. The animal feed additive of claim 19 , which further comprises of one or more amylases, galactanases, alpha-galactosidases, beta-glucanases, phospholipases, phytases, proteases, and xylanases, or any mixture thereof.

Assignees

Inventors

Classifications

  • Antibacterial agents · CPC title

  • by extrusion · CPC title

  • Lysozyme (3.2.1.17) · CPC title

  • A23K20/189Primary

    Enzymes · CPC title

  • Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10039300B2 cover?
The present invention relates to isolated polypeptides having lysozyme activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Who is the assignee on this patent?
Novozymes As
What technology area does this patent fall under?
Primary CPC classification A23K20/189. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).